Paul Collins is currently a Vice President and Senior Research Fellow for Bioproduct R&D at Eli Lilly and Company in Indianapolis. In his current role, Paul has responsibility for defining future technologies and development approaches for molecules associated with genetic medicine, as well as drug delivery of these entities. Paul has a long history in technology development across several areas of his company. Paul has worked in Bioproduct Development, Synthetic Technology Development, Synthetic Process Development, and Device and Drug Delivery.
During his...Read more
